Thermo Fisher Scientific opens viral vector manufacturing facility in Plainville, Massachusetts.
Search Patheon
Search
US | EN
The pharmaceutical industry is facing increasing pressures on quality, pricing and productivity. The traditional batch method of manufacturing oral solid dose medications has limited scope to address these needs. Thermo Fisher Scientific offers a new alternative to batch manufacturing.
Continuous manufacturing can deliver higher quality oral solid dose products, with greater flexibility and a reduced total cost of supply.